Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 25 | ETON Eton Pharmaceuticals | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 13 | 25,000 | 325.00 k | 25,000 |
11 Jun 24 | ISCO International Stem Cell | Stock Option Common Stock | Grant | Acquire A | No | No | 0.12 | 361,111 | 43.33 k | 361,111 |
11 Jun 24 | ISCO International Stem Cell | Stock Option Common Stock | Grant | Acquire A | No | No | 0.12 | 30,000 | 3.60 k | 30,000 |
7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 1.96 | 15,000 | 29.40 k | 0 |
7 Mar 24 | Ambrx Biopharma | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 1.96 | 30,000 | 58.80 k | 0 |
7 Mar 24 | Ambrx Biopharma | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 12,142 | 0.00 | 0 |
13 Feb 24 | ETON Eton Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.42 | 30,000 | 132.60 k | 164,555 |